March 30th, 2014
•Drug resistance testing for HIV-1 infected individuals failing antiretroviral therapy (ART) can guide future therapies and improve treatment outcomes. Optimizing individual and population health outcomes in high HIV prevalence but resource-limited settings will ultimately require affordable and accessible drug resistance genotyping and interpretation methods.
Videos relacionados
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Techniques for Processing Eyes Implanted with a Retinal Prosthesis for Localized Histopathological Analysis: Part 2 Epiretinal Implants with Retinal Tacks
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
An Improved Method for Rapid Intubation of the Trachea in Mice
Pancreatic Duct Infusion: An Effective and Selective Method of Drug and Viral Delivery
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados